Effect of amiloride on lithium-induced chronic nephropathy.Comparing discontinuation of lithium treatment to adding amiloride while continuing lithium treatment.

Parnassia-BAVO groep0 个研究点开始时间: 2009年2月13日最近更新: 2012年3月19日

试验速览

暂无简介。

•Patients are eliglible for participation in case of
•Long-term use of lithium treatment, defined as having used lithium for at least five years prior to inclusion.
•progressive renal faillure defined as an increase of plasma creatinine levels of at least 10umol/l/year for at least five years. with r2 >/= 0.85 and a maximal serum creatinine level of 200umol/L.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•patients with either hyper or hypotension. Use of antihypertensive medication is allowed.
•not being able to provide informed consent for participation

发起方

Parnassia-BAVO groep